Pemvidutide
Modify Date: 2024-01-03 18:11:42
Pemvidutide structure
|
Common Name | Pemvidutide | ||
|---|---|---|---|---|
| CAS Number | 2538014-94-5 | Molecular Weight | 3873.35 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C182H275N39O54 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PemvidutidePemvidutide is a GLP-1R/GCGR dual agonist, shows striking reductions in body weight, liver fat and serum lipids. Pemvidutide can be used in non-alcoholic steatohepatitis (NASH) and obesity research[1]. |
| Name | Pemvidutide |
|---|
| Description | Pemvidutide is a GLP-1R/GCGR dual agonist, shows striking reductions in body weight, liver fat and serum lipids. Pemvidutide can be used in non-alcoholic steatohepatitis (NASH) and obesity research[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Pemvidutide (subcutaneous injection; 5 or 10 nmol/kg; once daily; 12 w) treatment improves NASH (nonalcoholic steatohepatitis) outcomes in vivo[1]. Animal Model: C57BL6/J mice (with biopsy-confirmed NAS score after 29 weeks on a HFFC diet)[1] Dosage: 5 or 10 nmol/kg Administration: Subcutaneous injection; 5 or 10 nmol/kg; once daily; 12 weeks Result: Lowered hepatic lipids, liver weight, biomarkers of liver injury (plasma ALT and AST), the inflammation marker galactin-3, the fibrosis marker Col1a1, and the NAS score. |
| Molecular Formula | C182H275N39O54 |
|---|---|
| Molecular Weight | 3873.35 |